Icotinib Hydrochloride, CAS [[1204313-51-8]]

Produktübersicht

• Artikelname: Icotinib Hydrochloride, CAS [[1204313-51-8]]
• Artikelnummer: TGM-T2307
• Hersteller Artikelnummer: T2307
• Alternativnummer: TGM-T2307-1MLX10MM(INDMSO),TGM-T2307-5MG,TGM-T2307-10MG,TGM-T2307-25MG,TGM-T2307-50MG,TGM-T2307-100MG,TGM-T2307-200MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien
• Alternative Synonym: BPI-2009H

Produktbeschreibung

Icotinib Hydrochloride (BPI-2009H) is the hydrochloride salt form of icotinib, an orally available quinazoline-based inhibitor of EGFR, with potential antineoplastic activity. Icotinib selectively inhibits the wild-type and several mutated forms of EGFR tyrosine kinase. This may lead to an inhibition of EGFR-mediated signal transduction and may inhibit cancer cell proliferation. EGFR, a receptor tyrosine kinase, has been upregulated in a variety of cancer cell types.

Produkteigenschaften

• Molekulargewicht: 427.88
• Reinheit: 99.89%
• CAS Nummer: [1204313-51-8]
• Formel: C22H22ClN3O4
• Target-Kategorie: EGFR

Bilder

T2307